カテゴリ： FactMR, 世界, 医療/バイオ

メラノーマ癌診断のグローバル市場2023～2033：蛍光insituハイブリダイゼーション（FISH）検査、比較ゲノムハイブリダイゼーション（CGH）検査、免疫組織化学（IHC）検査

■ 英語タイトル：Melanoma Cancer Diagnostics Market Analysis, By Test (Fluorescent In-Situ Hybridization (FISH) Tests, Comparative Genomic Hybridization (CGH) Tests, Immunohistochemical (IHC) Tests), By End User (Hospitals, Pathology Laboratories, Cancer Research Centers), and Region - Global Market Insights 2023 to 2033

調査会社FactMR社が発行したリサーチレポート（データ管理コード：FACT23MA119）■ 発行会社/調査会社：FactMR
■ 商品コード：FACT23MA119
■ 発行日：2023年3月31日
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：約170
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single User（1名様閲覧、印刷不可）USD4,500 ⇒換算￥675,000見積依頼/購入/質問フォーム
Global Sie License（同一拠点内共有可）USD8,500 ⇒換算￥1,275,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※FactMR社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[メラノーマ癌診断のグローバル市場2023～2033：蛍光insituハイブリダイゼーション（FISH）検査、比較ゲノムハイブリダイゼーション（CGH）検査、免疫組織化学（IHC）検査]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Fact.MR社による最新調査レポートは、世界のメラノーマ癌診断市場について2023年度から2033年度までの10年間にわたる市場規模予測を掲載しています。本レポートは、エグゼクティブサマリー、市場概要、市場動向、主な内容、検査別（蛍光insituハイブリダイゼーション（FISH）検査、比較ゲノムハイブリダイゼーション（CGH）検査、免疫組織化学（IHC）検査）分析、エンドユーザー別（病院、病理研究所、癌研究センター）分析、地域別（北米、中南米、ヨーロッパ、ロシア、アジア太平洋、日本、中東・アフリカ）分析などの項目を掲載しています。
・エグゼクティブサマリー
・市場紹介
・市場動向
・主な内容
・世界のメラノーマ癌診断市場規模：検査別
- 蛍光insituハイブリダイゼーション（FISH）検査の市場規模
- 比較ゲノムハイブリダイゼーション（CGH）検査の市場規模
- 免疫組織化学（IHC）検査の市場規模
・世界のメラノーマ癌診断市場規模：エンドユーザー別
- 病院における市場規模
- 病理研究所における市場規模
- 癌研究センターにおける市場規模
・世界のメラノーマ癌診断市場規模：地域別
- 北米のメラノーマ癌診断市場規模
- 中南米のメラノーマ癌診断市場規模
- ヨーロッパのメラノーマ癌診断市場規模
- ロシアのメラノーマ癌診断市場規模
- アジア太平洋のメラノーマ癌診断市場規模
- 日本のメラノーマ癌診断市場規模
- 中東・アフリカのメラノーマ癌診断市場規模

本レポートには、各企業の製品ポートフォリオや主要戦略、包括的なSWOT分析などの要素を含む企業情報が含まれています。企業のプレゼンスは、全著名プレーヤーについてマッピングされ、マトリックスを通して提示されます。なお、購読者に実用的な洞察を提供し、熟考して市場の状況を示し、メラノーマ癌診断における競争レベルを推測するのに役立ちます。

Melanoma Cancer Diagnostics Market – Scope of Report

A recent study by Fact.MR on the melanoma cancer diagnostics market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering melanoma cancer diagnostics.

The study also provides the dynamics responsible for influencing the future status of the melanoma cancer diagnostics market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the melanoma cancer diagnostics market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of melanoma cancer diagnostics across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of melanoma cancer diagnostics during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for melanoma cancer diagnostics are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global melanoma cancer diagnostics market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the melanoma cancer diagnostics market during the forecast period.

Country-specific valuation on demand for melanoma cancer diagnostics has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of melanoma cancer diagnostics, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering melanoma cancer diagnostics has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the melanoma cancer diagnostics domain.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. Opportunity Assessment

    1.4. FACT.MR Analysis and Recommendations

    1.5. Wheel of FortuneTM – Opportunity Analysis

2. Market Introduction

    2.1. Market introduction

    2.2. Market definition

    2.3. Scope of Research

3. Market Dynamics

    3.1. Macro – Economic Factors Influencing Demand

    3.2. Key Growth Drivers and Impact Analysis

    3.3. Industry Challenges and Restraints

    3.4. Forecast Factors and Relevance of Impact

4. Key Inclusion

    4.1. Pricing Analysis by Test Type 2023

    4.2. Melanoma Cancer Country Wise Epidemiology, 2023

    4.3. Regulation and Reimbursement Scenario, 2023

    4.4. Melanoma Skin Cancer: Global Overview, 2023

    4.5. Melanoma Skin Cancer: Survival Rates, 2023

    4.6. Melanoma Skin Cancer: Higher Risk Countries Across Globe, 2023

5. Global Market Analysis and Forecast

    5.1. Global Market Outlook

        5.1.1. Market Value (US$ Mn) Forecast and Analysis

        5.1.2. Regional Demand Assessment

    5.2. Market Value Share by Region

    5.3. Global Market Analysis and Forecast, By Test Type

        5.3.1. Market Share Analysis By Test Type

        5.3.2. Y-o-Y Growth Projections By Test type

    5.4. Market Size Analysis By Test Type

        5.4.1. Fluorescent In Situ Hybridization (FISH) Tests

        5.4.2. Comparative Genomic Hybridization (CGH) Tests

        5.4.3. Immunohistochemical (IHC) Tests

    5.5. Market Attractiveness Analysis By Test Type

    5.6. Global Market Analysis and Forecast, By End User

        5.6.1. Market Share Analysis By End User

        5.6.2. Y-o-Y Growth Projections By End User

    5.7. Market Size Analysis By End User

        5.7.1. Hospitals

        5.7.2. Pathology Laboratories

        5.7.3. Cancer Research Centres

6. North America Market Analysis

    6.1. Introduction

        6.1.1. North America Business Outlook

        6.1.2. North America Market Outlook

    6.2. North America Market Outlook

        6.2.1. Market Value (US$ Mn) Forecast and Analysis

        6.2.2. Country Wise Demand Assessment

            6.2.2.1. US

            6.2.2.2. Canada

    6.3. North America Market Analysis by Test Type

        6.3.1. Value(US$ Mn) Forecast by Test Type

        6.3.2. Y-o-Y Growth Comparison by Test Type

    6.4. North America Market Analysis by End User

        6.4.1. Value(US$ Mn) Forecast by End User

        6.4.2. Y-o-Y Growth Comparison by End User

    6.5. Market Attractiveness Analysis

    6.6. Reimbursement scenario

7. Latin America Market Analysis

    7.1. Introduction

        7.1.1. Latin America Business Outlook

        7.1.2. Latin America Market Outlook

    7.2. Latin America Market Outlook

        7.2.1. Market Value (US$ Mn) Forecast and Analysis

        7.2.2. Country Wise Demand Assessment

            7.2.2.1. Mexico

            7.2.2.2. Brazil

            7.2.2.3. Argentina

    7.3. Latin America Market Analysis by Test Type

        7.3.1. Value(US$ Mn) Forecast by Test Type

        7.3.2. Y-o-Y Growth Comparison by Test Type

    7.4. Latin America Market Analysis by End User

        7.4.1. Value(US$ Mn) Forecast by End User

        7.4.2. Y-o-Y Growth Comparison by End User

    7.5. Market Attractiveness Analysis

    7.6. Reimbursement scenario

8. Europe Market Analysis

    8.1. Introduction

        8.1.1. Europe Business Outlook

        8.1.2. Europe Market Outlook

    8.2. Europe Market Outlook

        8.2.1. Market Value (US$ Mn) Forecast and Analysis

        8.2.2. Country Wise Demand Assessment

            8.2.2.1. Germany

            8.2.2.2. France

            8.2.2.3. UK

            8.2.2.4. Spain

            8.2.2.5. Italy

            8.2.2.6. Belgium

            8.2.2.7. Netherlands

    8.3. Europe Market Analysis by Test Type

        8.3.1. Value(US$ Mn) Forecast by Test Type

        8.3.2. Y-o-Y Growth Comparison by Test Type

    8.4. Europe Market Analysis by End User

        8.4.1. Value(US$ Mn) Forecast by End User

        8.4.2. Y-o-Y Growth Comparison by End User

    8.5. Market Attractiveness Analysis

    8.6. Reimbursement scenario

9. CIS & Russia Market Analysis

    9.1. Introduction

        9.1.1. CIS & Russia Business Outlook

        9.1.2. CIS & Russia Market Outlook

    9.2. CIS & Russia Market Outlook

        9.2.1. Market Value (US$ Mn) Forecast and Analysis

        9.2.2. Country Wise Demand Assessment

            9.2.2.1. CIS

            9.2.2.2. Russia

    9.3. CIS & Russia Market Analysis by Test Type

        9.3.1. Value(US$ Mn) Forecast by Test Type

        9.3.2. Y-o-Y Growth Comparison by Test Type

    9.4. CIS & Russia Market Analysis by End User

        9.4.1. Value(US$ Mn) Forecast by End User

        9.4.2. Y-o-Y Growth Comparison by End User

    9.5. Market Attractiveness Analysis

    9.6. Reimbursement scenario

10. Asia Pacific ex. Japan Market Analysis

    10.1. Introduction

        10.1.1. Asia Pacific ex. Japan Business Outlook

        10.1.2. Asia Pacific ex. Japan Market Outlook

    10.2. Asia Pacific ex. Japan Market Outlook

        10.2.1. Market Value (US$ Mn) Forecast and Analysis

        10.2.2. Country Wise Demand Assessment

            10.2.2.1. China

            10.2.2.2. India

            10.2.2.3. Australia

            10.2.2.4. New Zealand

            10.2.2.5. Thailand

    10.3. Asia Pacific ex. Japan Market Analysis by Test Type

        10.3.1. Value(US$ Mn) Forecast by Test Type

        10.3.2. Y-o-Y Growth Comparison by Test Type

    10.4. Asia Pacific ex. Japan Market Analysis by End User

        10.4.1. Value(US$ Mn) Forecast by End User

        10.4.2. Y-o-Y Growth Comparison by End User

    10.5. Market Attractiveness Analysis

    10.6. Reimbursement scenario

11. Japan Market Analysis

    11.1. Introduction

        11.1.1. Japan Business Outlook

        11.1.2. Japan Market Outlook

    11.2. Japan Market Outlook

        11.2.1. Market Value (US$ Mn) Forecast and Analysis

    11.3. Japan Market Analysis by Test Type

        11.3.1. Value(US$ Mn) Forecast by Test Type

        11.3.2. Y-o-Y Growth Comparison by Test Type

    11.4. Japan Market Analysis by End User

        11.4.1. Value(US$ Mn) Forecast by End User

        11.4.2. Y-o-Y Growth Comparison by End User

    11.5. Market Attractiveness Analysis

    11.6. Reimbursement scenario

12. MEA Market Analysis

    12.1. Introduction

        12.1.1. MEA Business Outlook

        12.1.2. MEA Market Outlook

    12.2. MEA Market Outlook

        12.2.1. Market Value (US$ Mn) Forecast and Analysis

        12.2.2. Country Wise Demand Assessment

            12.2.2.1. South Africa

            12.2.2.2. Turkey

            12.2.2.3. GCC

    12.3. MEA Market Analysis by Test Type

       12.3.1. Value(US$ Mn) Forecast by Test Type

       12.3.2. Y-o-Y Growth Comparison by Test Type

    12.4. MEA Market Analysis by End User

        12.4.1. Value(US$ Mn) Forecast by End User

        12.4.2. Y-o-Y Growth Comparison by End User

    12.5. Market Attractiveness Analysis

    12.6. Reimbursement scenario

13. Assumptions and Acronyms Used

14. Research Methodology

Table 01: US Average Test Price (US$), By Test Type

Table 02: Canada Average Test Price (US$), By Test Type

Table 03: Germany Average Test Price (US$), By Test Type

Table 04: France Average Test Price (US$), By Test Type

Table 05: U.K. Average Test Price (US$), By Test Type

Table 06: Spain Average Test Price (US$), By Test Type

Table 07: Italy Average Test Price (US$), By Test Type

Table 08: Australia Average Test Price (US$), By Test Type

Table 09: Market: Regulation and Reimbursement Scenario

Table 10: Global Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By Region

Table 11: Global Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By Test Type

Table 12: Global Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By End User

Table 13: North America Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By Country

Table 14: North America Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By Test Type

Table 15: North America Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By End User

Table 16: Latin America Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By Country

Table 17: Latin America Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By Test Type

Table 18: Latin America Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By End User

Table 19: Europe Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By Country

Table 20: Europe Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By Test Type

Table 21: Europe Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By End User

Table 22: CIS & Russia Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By Country

Table 23: CIS & Russia Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By Test Type

Table 24: CIS & Russia Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By End User

Table 25: APEJ Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By Country

Table 26: APEJ Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By Test Type

Table 27: APEJ Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By End User

Table 28: Japan Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By Test Type

Table 29: Japan Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By End User

Table 30: Middle East & Africa Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By Country

Table 31: Middle East & Africa Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By Test Type

Table 32: Middle East & Africa Market Size (US$ Mn) Analysis 2018–2022 and Forecast 2023–2033, By End User

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 蛍光in situハイブリダイゼーションプローブのグローバル市場2023-2030：フローFISH、Q FISH
  • In Situハイブリダイゼーション(ISH)のグローバル市場（2024～2030）：FISH、CISH
  • 免疫組織化学（IHC）の世界市場2023～2027
  • 世界のin situハイブリダイゼーション（ISH）市場2023-2030：蛍光in situハイブリダイゼーション（FISH）、発色in situハイブリダイゼーション（CISH）
  • コンパニオン診断のグローバル市場（2022年-2029年）：免疫組織化学（IHC）、ポリメラーゼ連鎖反応（PCR）、In-situハイブリダイゼーション（ISH）、リアルタイムPCR（RT-PCR）、遺伝子シーケンス＆その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(FACT23MA119 )"メラノーマ癌診断のグローバル市場2023～2033：蛍光insituハイブリダイゼーション（FISH）検査、比較ゲノムハイブリダイゼーション（CGH）検査、免疫組織化学（IHC）検査" (英文：Melanoma Cancer Diagnostics Market Analysis, By Test (Fluorescent In-Situ Hybridization (FISH) Tests, Comparative Genomic Hybridization (CGH) Tests, Immunohistochemical (IHC) Tests), By End User (Hospitals, Pathology Laboratories, Cancer Research Centers), and Region - Global Market Insights 2023 to 2033)はFactMR社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。